Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Health Risk Morning Hypertension - Now Detectable With the New Omron M10-IT Digital Automatic Blood Pressure Monitor.
- HOOFDDORP, The Netherlands, August 31 /PRNewswire/ -- Morning Hypertension has been identified as a major health risk for those susceptible to high blood pressure. When waking up, many of us experience a condition called "Morning Surge" HOOFDDORP, The Netherlands, August 31 /PRNewswire/...
- Research articles 2007-08-31
- Newspapers
- The decline of the newspaper means ransom notes, papier-mâché and slacker gift wrapping will never be the same.
- Videos 2008-07-02
- Novartis Announces Efficacy Data on New Investigational High Blood Pressure Therapies at the American Society of Hypertension Annual Meeting
- -- Studies show Rasilez® aliskiren, investigational agent in a new class of direct renin inhibitors, provides significant blood pressure reductions, sustained over 24 hours -- New Exforge® (amlodipine besylate/valsartan) data show dual mechanism of action...
- Research articles 2006-05-17
- Repeat - Novartis Announces Efficacy Data on New Investigational High Blood Pressure Therapies at the American Society of Hypertension Annual Meeting
- -- Studies show Rasilez® aliskiren, investigational agent in a new class of direct renin inhibitors, provides significant blood pressure reductions, sustained over 24 hours -- New Exforge® (amlodipine besylate/valsartan) data show dual mechanism of action...
- Research articles 2006-05-17
- Top Seven Workplace Plays and Maneuvers
- All office politicking relies upon a simple concept: the biggest help and the biggest hindrance to reaching your goals is other people. What's the right way to win friends and influence people? The most effective moves build alliances, sell your ideas, and solve problems. They also involve risk — so...
- Articles 2007-07-02
- PFIZER INC - Research Update.
- New Data Show Hypertensive Patients Taking Norvasc-Based Regimen Achieved Better Central Blood Pressure Control Central Blood Pressure Shown to Be an Independent Predictor of Cardiovascular ...
- Research articles 2005-11-14
- Novartis' Busy Week
- A tablet that inhibits an enzyme produced by the kidney and an antifungal ointment were on the menu for Novartis last week. The Swiss drugmaker received approval from the U.S. Food and Drug Administration for Tekturna, a blood pressure medicine that is the first approved by the federal agency to...
- Research articles 2007-03-12
- OMRON Digital Thermometer Wins iF Product Design Gold Award; HEM-1010-E Blood Pressure Monitor Also Recognized
- Tokyo, Japan, Apr 10, 2007 - JCN Newswire - Omron Healthcare Co., Ltd., a wholly owned subsidiary of OMRON Corporation (TSE:6645; ADR: OMRNY) today announced that its i-Temp digital thermometer (model MC-670-E), which will debut in Europe this October, won a Gold Award at the iF Product Design Awards...
- Research articles 2007-04-10
- Concord Grape Juice Lowered Blood Pressure in Preliminary Clinical Study; Also Lowered BP, Cholesterol and Inhibited Atherosclerosis in Lab Study
- SAN DIEGO, Calif. -- Concurrent Studies Point to Positive Effect on Blood Pressure, Other Cardiovascular Risk Factors
- Research articles 2005-04-04
- Omron Healthcare to Introduce New Upper Arm Blood Pressure Monitor
- Omron Healthcare announced on April 21 that it will begin marketing HEM-5001 MediNote, a new model of its upper arm blood pressure monitor, on April 25.
- Research articles 2005-04-25
- eFoodSafety.com, Inc. Announces: Expanded Study Results Confirm Additional Benefits from Cinnechol™ in Reducing Blood Pressure as Well as Cholesterol Levels
- SCOTTSDALE, Ariz. -- eFoodSafety.com, Inc. (OTCBB:EFSF) is pleased to confirm that during the initial phase of testing Cinnechol[TM] for the treatment of elevated cholesterol, an expanded study showed a very strong and totally unexpected benefit of reducing blood pressure among study participants showing symptoms of hypertension. Within this group taking...
- Research articles 2007-09-27
- The Medicines Company's Second Pivotal Efficacy Trial of Clevelox -Clevidipine- Meets Objectives; Clevelox ESCAPE-1 Trial Demonstrates Blood Pressure Lowering Effect
- PARSIPPANY, N.J. -- The Medicines Company (Nasdaq:MDCO) today released primary results of the ESCAPE-1 clinical trial of CleveloxTM clevidipine, an intravenous blood pressure control agent in Phase III development. ESCAPE-1 results met the pre-specified trial objectives. Cardiac surgery patients with high blood pressure treated with Clevelox achieved treatment success 92.5%...
- Research articles 2004-12-16
- Studies of the Relationship between Blood Pressure and Cognitive Impairment Require Participants Be Free of Dementia at Time of Enrollment
- PASADENA, Calif. -- A study published in the January, 2005 edition of the Archives of Neurology indicates that contradictory results of various studies into the relationship between high blood pressure and dementia may be caused by inconsistencies in the ages and conditions of study participants.
- Research articles 2005-01-18
- FDA Approves Higher Dose Formulations of Diovan HCT(R) (Valsartan/Hydrochlorothiazide) for Treatment of High Blood Pressure
- The U.S. Food and Drug Administration FDA approved two new, higher dose formulations of the high blood pressure medication Diovan HCT® (valsartan/hydrochlorothiazide): 320/12.5 mg and 320/25 mg. The approval of the higher strengths of Diovan HCT provides more options to help physicians more effectively manage their patients' high blood...
- Research articles 2006-05-01
- Medtronic Evaluates Remote Monitoring of Heart Activity, Weight and Blood Pressure in Heart Failure Patients
- MINNEAPOLIS -- Medtronic, Inc. (NYSE:MDT), today announced it has begun a U.S. pilot evaluation with Carematix, Inc. to assess the efficacy and convenience of remotely monitoring physiological heart data, weight and blood pressure in the management of heart failure.
- Research articles 2005-05-03
- SAMSUNG JUMPS INTO WELLNESS; LINE OF BLOOD PRESSURE MONITORS TO BE LAUNCHED IN JANUARY.(Brief Article)(Statistical Data Included)
- RIDGEFIELD, NJ-Hoping to capitalize on its well-known brand name, Samsung America has created a home healthcare division. This month, the company unveiled its first healthcare products in the United States -- a line of blood pressure monitors. RIDGEFIELD, NJ-Hoping to capitalize on its...
- Research articles 1999-11-29
- Molecular Biology 9:00 am Saturday, April 6, 2002 Battelle Hall 144 Daniel J. Kaser-Presiding
- 9:00 NITRIC OXIDE AND ENDOTHELIAL NITRIC OXIDE SYNTHASE MAY PRODUCE A HYPOTENSIVE EFFECT IN A LOW BLOOD PRESSURE LINE OF WISTAR-KYOTO WKY RAT. Colin M. Everhart, (Daniel L. Ely, ely1@uakron.edu) Dept. of Biology, University of Akron, Akron OH 44325-3908. The hypothesis tested was that a greater amount of endothelial nitric...
- Research articles 2002-03-01
- US Submission of Exforge(R) Accepted for Review By the FDA as a New Therapy Option for High Blood Pressure
- Novartis announced today that the new drug application NDA for Exforge® (amlodipine besylate/valsartan) was accepted for standard review by the US Food and Drug Administration FDA as a new treatment option for people with high blood pressure. The submission for EU approval was completed earlier in 2006.
- Research articles 2006-04-27
- Biovail Corporation: Blood Pressure Medication is Not Administered to Best Protect Against Heart Attack, Stroke.
- NEW YORK, NEW YORK, May 17, 2002 NEW YORK, NEW YORK, May 17, 2002
- Research articles 2002-05-20
- Criticare Systems, Inc. Announces Release of Innovative New Blood Pressure Measurement Technology
- MILWAUKEE -- CRITICARE SYSTEMS, INC. (AMEX:CMD). Criticare Systems, Inc. today announced the release of a new technology platform for non-invasive blood pressure measurement utilizing a traditional BP cuff. This system is based on the Criticare pioneered "on inflation" principal but adds a greater level of patient comfort, safety, accuracy, reading...
- Research articles 2005-03-04
- << Previous
- page 1 of 3
- Next >>
Content Types
Refining Tags
